“The company’s Australian chief executive Rohan Hockings said there were about 50 people with the condition in Perth.“There’s a well-characterised, identified patient population here in Perth with this disease and they don’t have any treatment options today,” Dr Rohan said.”
regulatory validation milestone achieved! well done all - good coverage by the local paper - looks like patients are lined up for clinical trials:
https://thewest.com.au/news/health/pyc-therapeutics-lands-fda-clearance-for-retinitis-pigmentosa-treatment-drug-c-9952698.amp
- Forums
- ASX - By Stock
- Ann: FDA Clears PYC to Commence First Human Trials in RP11
PYC
pyc therapeutics limited
Add to My Watchlist
3.54%
!
$1.17

“The company’s Australian chief executive Rohan Hockings said...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.17 |
Change
0.040(3.54%) |
Mkt cap ! $670.7M |
Open | High | Low | Value | Volume |
$1.15 | $1.17 | $1.11 | $96.90K | 85.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 652 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 717 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 652 | 1.160 |
2 | 5044 | 1.155 |
1 | 2647 | 1.150 |
1 | 2073 | 1.145 |
2 | 2499 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 717 | 2 |
1.175 | 9809 | 2 |
1.180 | 20836 | 4 |
1.185 | 410 | 1 |
1.190 | 426 | 1 |
Last trade - 13.07pm 20/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |